Battling cystic fibrosis.(Cystic Fibrosis Foundation provides funds to Genaera Corp. to develop Lomucin)(Brief Article)

Genaera Corp. of Plymouth Meeting received a $1.7 million grant from the Cystic Fibrosis Foundation to develop a drug, Lomucin, that inhibits the excess production of mucus that clogs the small airways in chronic diseases like cystic fibrosis, asthma and chronic obstructive pulmonary disease.

The company plans to use the foundation's therapeutics development program grant to support the early clinical evaluation of the new drug candidate in patients with cystic fibrosis.

Cystic fibrosis is the most common fatal genetic disease in the United States. It affects about 30,000 children and young adults. The disease causes the body to produce an abnormally thick …